{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:44:21Z","timestamp":1782830661482,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-026-04256-w","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:24:41Z","timestamp":1778088281000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["What is the optimal antiplatelet therapy in patients with chronic coronary syndrome undergoing coronary artery bypass grafting?"],"prefix":"10.1186","volume":"21","author":[{"given":"Sleiman Sebastian","family":"Aboul-Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartlomiej","family":"Perek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Kowalewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Pieszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slawomir","family":"Mierzwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Stankowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Gaudino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Sandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romuald","family":"Cichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"17","key":"4256_CR1","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1093\/eurheartj\/ehz714","volume":"41","author":"E Bj\u00f6rklund","year":"2020","unstructured":"Bj\u00f6rklund E, Nielsen SJ, Hansson EC, et al. Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry. Eur Heart J. 2020;41(17):1653\u201361. https:\/\/doi.org\/10.1093\/eurheartj\/ehz714.","journal-title":"Eur Heart J"},{"issue":"10","key":"4256_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","volume":"131","author":"A Kulik","year":"2015","unstructured":"Kulik A, Ruel M, Jneid H, et al. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association. Circulation. 2015;131(10):927\u201364. https:\/\/doi.org\/10.1161\/CIR.0000000000000182.","journal-title":"Circulation"},{"issue":"1","key":"4256_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezae355","volume":"67","author":"A Jeppsson","year":"2024","unstructured":"Jeppsson A, Rocca B, Hansson EC, et al. 2024 EACTS guidelines on perioperative medication in adult cardiac surgery. Eur J Cardiothorac Surg. 2024;67(1):ezae355. https:\/\/doi.org\/10.1093\/ejcts\/ezae355.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"4256_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/1010-7940(93)90155-5","volume":"7","author":"SE Fremes","year":"1993","unstructured":"Fremes SE, Levinton C, Naylor CD, Chen E, Christakis GT, Goldman BS. Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis. Eur J Cardiothorac Surg. 1993;7(4):169\u201380. https:\/\/doi.org\/10.1016\/1010-7940(93)90155-5.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"4256_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1569-9293(03)00181-6","volume":"2","author":"G Musleh","year":"2003","unstructured":"Musleh G, Dunning J. Does aspirin 6 h after coronary artery bypass grafting optimise graft patency? Interact Cardiovasc Thorac Surg. 2003;2(4):413\u20135. https:\/\/doi.org\/10.1016\/S1569-9293(03)00181-6.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"4","key":"4256_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S1569-9293(03)00202-0","volume":"2","author":"J Dunning","year":"2003","unstructured":"Dunning J, Das S. What is the optimal dose of aspirin after discharge following coronary bypass surgery. Interact Cardiovasc Thorac Surg. 2003;2(4):427\u201330. https:\/\/doi.org\/10.1016\/S1569-9293(03)00202-0.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"7427","key":"4256_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7427.1309","volume":"327","author":"E Lim","year":"2003","unstructured":"Lim E, Ali Z, Ali A, et al. Indirect comparison meta-analysis of aspirin therapy after coronary surgery. BMJ. 2003;327(7427):1309. https:\/\/doi.org\/10.1136\/bmj.327.7427.1309. (Erratum in: BMJ. 2004 Jan 17;328(7432):147.).","journal-title":"BMJ"},{"issue":"7","key":"4256_CR8","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMoa010746","volume":"345","author":"S Yusuf","year":"2001","unstructured":"Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345(7):494\u2013502. https:\/\/doi.org\/10.1056\/NEJMoa010746. (Erratum in: N Engl J Med 2001;345(23):1716. Erratum in: N Engl J Med 2001 Nov 15;345(20):1506.).","journal-title":"N Engl J Med"},{"issue":"11","key":"4256_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045\u201357. https:\/\/doi.org\/10.1056\/NEJMoa0904327.","journal-title":"N Engl J Med"},{"issue":"20","key":"4256_CR10","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001\u201315. https:\/\/doi.org\/10.1056\/NEJMoa0706482.","journal-title":"N Engl J Med"},{"key":"4256_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12893-015-0096-z","volume":"15","author":"S Verma","year":"2015","unstructured":"Verma S, Goodman SG, Mehta SR, et al. Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials. BMC Surg. 2015;15:112. https:\/\/doi.org\/10.1186\/s12893-015-0096-z.","journal-title":"BMC Surg"},{"issue":"4","key":"4256_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/jocs.12144","volume":"28","author":"J L\u00f3pez","year":"2013","unstructured":"L\u00f3pez J, Morales C, Avanzas P, Callejo F, Hern\u00e1ndez-Vaquero D, Llosa JC. Long-term effect of dual antiplatelet treatment after off-pump coronary artery bypass grafting. J Card Surg. 2013;28(4):366\u201372. https:\/\/doi.org\/10.1111\/jocs.12144.","journal-title":"J Card Surg"},{"issue":"6","key":"4256_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jama.2022.11966","volume":"328","author":"S Sandner","year":"2022","unstructured":"Sandner S, Redfors B, Angiolillo DJ, et al. Association of dual antiplatelet therapy with ticagrelor with vein graft failure after coronary artery bypass graft surgery: a systematic review and meta-analysis. JAMA. 2022;328(6):554\u201362. https:\/\/doi.org\/10.1001\/jama.2022.11966.","journal-title":"JAMA"},{"key":"4256_CR14","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"JP Vandenbroucke","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12:1500\u201324.","journal-title":"Int J Surg"},{"key":"4256_CR15","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0735-1097(99)00250-8","volume":"34","author":"MS Lauer","year":"1999","unstructured":"Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999;34:618\u201320.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"4256_CR16","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/0735-1097(96)00206-9","volume":"28","author":"GM Fitzgibbon","year":"1996","unstructured":"Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28(3):616\u201326. https:\/\/doi.org\/10.1016\/0735-1097(96)00206-9.","journal-title":"J Am Coll Cardiol"},{"key":"4256_CR17","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jtcvs.2007.07.021","volume":"134","author":"PC Austin","year":"2007","unstructured":"Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg. 2007;134:1128\u201335.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4256_CR18","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/ejcts\/ezy167","volume":"53","author":"U Benedetto","year":"2018","unstructured":"Benedetto U, Head SJ, Angelini GD, et al. Statistical pri-mer: propensity score matching and its alternatives. Eur J Cardiothorac Surg. 2018;53:1112\u20137.","journal-title":"Eur J Cardiothorac Surg"},{"key":"4256_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity\u2010score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150\u201361.","journal-title":"Pharm Stat"},{"key":"4256_CR20","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/aje\/kwq224","volume":"172","author":"PC Austin","year":"2010","unstructured":"Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol. 2010;172:1092\u20137.","journal-title":"Am J Epidemiol"},{"key":"4256_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/00273171.2011.540480","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. A tutorial and case study in propensity score analysis: an application to estimate the effect of in-hospital smoking cessation counseling on mortality. Multivariate Behav Res. 2011;46:119\u201351.","journal-title":"Multivariate Behav Res"},{"key":"4256_CR22","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1093\/eurheartj\/ehs186","volume":"33","author":"GS Collins","year":"2012","unstructured":"Collins GS, Le Manach Y. Comparing treatment effects between propensity scores and randomized controlled trials: improving conduct and reporting. Eur Heart J. 2012;33:1867\u20139.","journal-title":"Eur Heart J"},{"key":"4256_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezaf243","author":"S Sandner","year":"2025","unstructured":"Sandner S, Gaudino M, Agewall S, et al. Antithrombotic therapy after coronary artery bypass graft surgery: a clinical consensus statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2025. https:\/\/doi.org\/10.1093\/ejcts\/ezaf243.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"4256_CR24","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.atssr.2024.11.012","volume":"3","author":"IA Ch","year":"2024","unstructured":"Ch IA, Latif F, Usmani A, et al. Dual Antiplatelet Therapy After Elective Coronary Artery Bypass Graft and Its Impact on Clinical Outcomes. Ann Thorac Surg Short Rep. 2024;3(2):408\u201313. https:\/\/doi.org\/10.1016\/j.atssr.2024.11.012.","journal-title":"Ann Thorac Surg Short Rep"},{"issue":"5","key":"4256_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/heartjnl-2023-323097","volume":"110","author":"A Agrawal","year":"2024","unstructured":"Agrawal A, Kumar A, Majid M, et al. Optimal antiplatelet strategy following coronary artery bypass grafting: a meta-analysis. Heart. 2024;110(5):323\u201330. https:\/\/doi.org\/10.1136\/heartjnl-2023-323097.","journal-title":"Heart"},{"key":"4256_CR26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2508026","author":"A Jeppsson","year":"2025","unstructured":"Jeppsson A, James S, Moller CH, et al. Ticagrelor and aspirin or aspirin alone after coronary surgery for acute coronary syndrome. N Engl J Med. 2025. https:\/\/doi.org\/10.1056\/NEJMoa2508026.","journal-title":"N Engl J Med"},{"issue":"10","key":"4256_CR27","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/heartjnl-2015-308691","volume":"102","author":"J Saw","year":"2016","unstructured":"Saw J, Wong GC, Mayo J, et al. Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery. Heart. 2016;102(10):763\u20139. https:\/\/doi.org\/10.1136\/heartjnl-2015-308691.","journal-title":"Heart"},{"issue":"5","key":"4256_CR28","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1067\/mtc.2001.111416","volume":"121","author":"N Zimmermann","year":"2001","unstructured":"Zimmermann N, Kienzle P, Weber AA, et al. Aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2001;121(5):982\u20134. https:\/\/doi.org\/10.1067\/mtc.2001.111416.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"4256_CR29","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1053\/j.jvca.2011.12.004","volume":"26","author":"F Bednar","year":"2012","unstructured":"Bednar F, Tencer T, Plasil P, et al. Evaluation of aspirin\u2019s effect on platelet function early after coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 2012;26(4):575\u201380. https:\/\/doi.org\/10.1053\/j.jvca.2011.12.004. (Epub 2012 Jan 26).","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"4256_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.thromres.2016.11.018","volume":"149","author":"T Ivert","year":"2017","unstructured":"Ivert T, Dal\u00e9n M, Ander C, et al. Platelet function one and three months after coronary bypass surgery in relation to once or twice daily dosing of acetylsalicylic acid. Thromb Res. 2017;149:64\u20139. https:\/\/doi.org\/10.1016\/j.thromres.2016.11.018.","journal-title":"Thromb Res"},{"issue":"14","key":"4256_CR31","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1093\/eurheartj\/ehab096","volume":"42","author":"M Gaudino","year":"2021","unstructured":"Gaudino M, Di Franco A, Bhatt DL, et al. The association between coronary graft patency and clinical status in patients with coronary artery disease. Eur Heart J. 2021;42(14):1433\u201341. https:\/\/doi.org\/10.1093\/eurheartj\/ehab096.","journal-title":"Eur Heart J"},{"issue":"17","key":"4256_CR32","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1161\/CIRCULATIONAHA.123.064090","volume":"148","author":"M Gaudino","year":"2023","unstructured":"Gaudino M, Sandner S, An KR, et al. Graft failure after coronary artery bypass grafting and its association with patient characteristics and clinical events: a pooled individual patient data analysis of clinical trials with imaging follow-up. Circulation. 2023;148(17):1305\u201315. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.064090.","journal-title":"Circulation"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-04256-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04256-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-04256-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:49:33Z","timestamp":1782827373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-04256-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4256"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-04256-w","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Ethics Committee of University of Zielona Gora(RCM-CM-KBUZ.001.34.2025).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Individual patient consent was waived because of the study\u2019s retrospective design and the data collection from routine care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"454"}}